Full-year sales reached $26.8 billion, driven by robust performance across HIV, oncology, and liver disease portfolios. HIV sales grew 8% year-over-year to $19.6 billion in 2024, exceeding ...

BofA analyst Tim Anderson lowered the firm’s price target on Moderna (MRNA) to $34 from $41 and keeps an Underperform rating on the shares ...

BofA analyst Tim Anderson raised the firm’s price target on Eli Lilly (LLY) to $1,000 from $997 and keeps a Buy rating on the shares after ...

Terence Flynn, Morgan Stanley, inquired about Zepbound payer dynamics and access. Patrik Jonsson explained that Medicare coverage related to obstructive sleep apnea (OSA) is anticipated in the second ...

Here are seven attractively valued dividend stocks investors can bet on for the long term, according to Bank of America ...

Analysts expect the Indianapolis, Indiana-based company to report quarterly earnings at $5.08 per share, up from $2.49 per ...

Two-time All-Star shortstop Tim Anderson has agreed to a minor league contract with the Los Angeles Angels and will report to ...

R emember All-Star shortstop Tim Anderson? Anderson has now signed a minor league contract with the Los Angeles Angels after ...

Hertzman, Senior Vice President and Chief Financial Officer, will participate in the BofA Securities 2025 Financial Services Conference on Tuesday, February 11, 2025. While there will be no ...

Armanino Foods of Distinction, Inc. (OTCQX: AMNF) announced today that Timothy W. Anderson has informed the Board of Directors that he will resign as President and Chief Executive Officer and as a ...

Small-cap stocks appear riskier after interest rates in the bond market recently spiked, with the Russell 2000 index now in correction territory. The Russell 2000 index RUT, a broad gauge of ...

Waxing bullish about the effects of Novo Nordisk's latest findings on Eli Lilly sentiment was Bank of America Securities analyst Tim Anderson. On the back of those clinical trial results ...